(Peltier Alexandre[Author]) - Search Results

Year	Number of Results
2003	1
2006	1
2009	1
2011	2
2012	2
2013	1
2014	7
2015	8
2016	7
2017	8
2018	3
2019	5
2020	5
2021	9
2022	15
2023	22
2024	14
2025	4
2026	4

1

Targeted microwave ablation of localised prostate cancer (VIOLETTE trial): a prospective multicentre study.

Delongchamps NB, Peltier A, Potiron E, Bladou F, Diamand R, Messas A, Roche JB, Robert G, Hoepffner JL, Piechaud T, Anract J, Velthoven RV. Delongchamps NB, et al. Among authors: peltier a. BJU Int. 2026 Mar 11. doi: 10.1111/bju.70220. Online ahead of print. BJU Int. 2026. PMID: 41810596

2

Targeted, Perilesional, and Distant Biopsies in Prostate Cancer.

Baboudjian M, Uleri A, Anract J, Brabant L, Assenmacher G, Baudewyns A, Peyrottes A, Sanguedolce F, Fiard G, Renard-Penna R, Hubner N, Messas A, Windisch O, Long-Depaquit T, Toledano H, Sordelli F, Colinet V, Bastide C, Peltier A, Ploussard G, Diamand R. Baboudjian M, et al. Among authors: peltier a. Eur Urol Oncol. 2026 Feb 23:S2588-9311(26)00043-X. doi: 10.1016/j.euo.2026.02.006. Online ahead of print. Eur Urol Oncol. 2026. PMID: 41735130

3

Radiomics and Image-based Artificial Intelligence for Predicting Recurrence and Survival After Surgery in Localized Renal Cell Carcinoma: An APPRAISE-AI Systematic Review and Meta-analysis.

Mjaess G, Diamand R, Dikete N, Kwong JCC, Pezzullo M, Margue G, Pasoglou V, Michoux N, Campi R, Amparore D, Aoun F, Albisinni S, Haroun P, Van Damme J, Peltier A, Bernhard JC, Zlotta AR, Tombal B, Quackels T, Roumeguère T. Mjaess G, et al. Among authors: peltier a. Eur Urol Focus. 2026 Jan 12:S2405-4569(25)00397-9. doi: 10.1016/j.euf.2025.12.017. Online ahead of print. Eur Urol Focus. 2026. PMID: 41530034 Review.

4

Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004).

Mjaess G, Quackels T, Fantoni JC, Tricard T, Marcq G, Blanc J, Barthelemy P, Carnot A, Sideris S, Awada A, Chanza NM, Peltier A, Albisinni S, Diamand R, Roumeguère T. Mjaess G, et al. Among authors: peltier a. World J Urol. 2026 Jan 13;44(1):90. doi: 10.1007/s00345-026-06192-9. World J Urol. 2026. PMID: 41528535 Clinical Trial.

5

The prognostic value of PTEN expression in localized prostate cancer.

Bellouti A, Sirtaine N, Roumeguere T, Peltier A, Diamand R. Bellouti A, et al. Among authors: peltier a. World J Urol. 2025 Aug 25;43(1):509. doi: 10.1007/s00345-025-05853-5. World J Urol. 2025. PMID: 40853393

6

Magnetic resonance imaging-targeted biopsy and accuracy with radical prostatectomy specimens: a grading issue.

Nguyen M, Mouhaoui O, Van Eycken M, El Kaddouri H, Roumeguere T, Peltier A, Diamand R. Nguyen M, et al. Among authors: peltier a. World J Urol. 2025 Jul 25;43(1):456. doi: 10.1007/s00345-025-05787-y. World J Urol. 2025. PMID: 40711515

7

National Belgian survey on managing non-muscle invasive bladder cancer during Mitomycin and bacillus Calmette-Guerin shortage.

Bertrand A, Roumeguere T, Vandamme J, Spinoit AF, Herve F, Assenmacher C, Decaestecker K, Peltier A, Di Gregorio M, Degraeve A; behalf of the Société Belge d’Urologie (SBU), the Belgische Vereniging voor Urologie (BVU). Bertrand A, et al. Among authors: peltier a. Fr J Urol. 2025 Aug;35(6-7):102905. doi: 10.1016/j.fjurol.2025.102905. Epub 2025 May 15. Fr J Urol. 2025. PMID: 40381849

8

Targeted microwave ablation of localised prostate cancer: Initial results of VIOLETTE trial.

Delongchamps NB, Peltier A, Potiron E, Bladou F, Anract J, Diamand R, Robert G, Messas A, Van Velthoven R. Delongchamps NB, et al. Among authors: peltier a. BJUI Compass. 2024 Oct 30;5(12):1307-1313. doi: 10.1002/bco2.444. eCollection 2024 Dec. BJUI Compass. 2024. PMID: 39744070 Free PMC article.

9

The massive 2016 marine heatwave in the Southwest Pacific: An "El Niño-Madden-Julian Oscillation" compound event.

Dutheil C, Lal S, Lengaigne M, Cravatte S, Menkès C, Receveur A, Börgel F, Gröger M, Houlbreque F, Le Gendre R, Mangolte I, Peltier A, Meier HEM. Dutheil C, et al. Among authors: peltier a. Sci Adv. 2024 Oct 11;10(41):eadp2948. doi: 10.1126/sciadv.adp2948. Epub 2024 Oct 9. Sci Adv. 2024. PMID: 39383217 Free PMC article.

10

Active surveillance for low-risk prostate cancer with high tumor burden at biopsy: lessons learned from a contemporary radical prostatectomy cohort.

Oliva J, Anastay V, Baboudjian M, Roumiguié M, Peltier A, Dariane C, Fiard G, Roumeguère T, Diamand R, Bakhri M, Beauval JB, Long-Depaquit T, Ploussard G, Uleri A. Oliva J, et al. Among authors: peltier a. World J Urol. 2024 Sep 9;42(1):513. doi: 10.1007/s00345-024-05227-3. World J Urol. 2024. PMID: 39251425

11

Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.

Mjaess G, Haddad L, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Abou Zahr R, Ploussard G, Fiard G, Halinski A, Rysankova K, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Bui AP, Taha F, Windisch O, Benamran D, Assenmacher G, Benijts J, Guenzel K, Roumeguère T, Peltier A, Diamand R. Mjaess G, et al. Among authors: peltier a. Prostate Cancer Prostatic Dis. 2025 Mar;28(1):173-179. doi: 10.1038/s41391-024-00872-6. Epub 2024 Jul 24. Prostate Cancer Prostatic Dis. 2025. PMID: 39048664

12

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

Diamand R, Guenzel K, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A. Diamand R, et al. Among authors: peltier a. World J Urol. 2024 Jun 12;42(1):372. doi: 10.1007/s00345-024-05068-0. World J Urol. 2024. PMID: 38866949

13

The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.

Baudewyns A, Guenzel K, Halinski A, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Jabbour T, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Zahr RA, Ploussard G, Fiard G, Rysankova K, Bui AP, Taha F, Windisch O, Benamran D, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A, Diamand R. Baudewyns A, et al. Among authors: peltier a. World J Urol. 2024 May 15;42(1):322. doi: 10.1007/s00345-024-04962-x. World J Urol. 2024. PMID: 38747982

14

Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study.

Peltier A, van Velthoven R, Baudewyns A, Assenmacher G, Lemort M, Lefebvre Y, Sirtaine N, Diamand R. Peltier A, et al. BJU Int. 2024 Aug;134(2):258-267. doi: 10.1111/bju.16385. Epub 2024 May 14. BJU Int. 2024. PMID: 38742416 Clinical Trial.

15

Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.

Diamand R, Roche JB, Lacetera V, Simone G, Windisch O, Benamran D, Fourcade A, Fournier G, Fiard G, Ploussard G, Roumeguère T, Peltier A, Albisinni S. Diamand R, et al. Among authors: peltier a. World J Urol. 2024 Apr 22;42(1):247. doi: 10.1007/s00345-024-04966-7. World J Urol. 2024. PMID: 38647728

16

Transrectal prostate biopsy: easy, effective and safe.

Diamand R, Peltier A, Albisinni S. Diamand R, et al. Among authors: peltier a. Prostate Cancer Prostatic Dis. 2024 Sep;27(3):363-364. doi: 10.1038/s41391-024-00823-1. Epub 2024 Apr 16. Prostate Cancer Prostatic Dis. 2024. PMID: 38627538 No abstract available.

17

Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.

Diamand R, Guenzel K, Mjaess G, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Benijts J, Assenmacher G, Roumeguère T, Peltier A. Diamand R, et al. Among authors: peltier a. Eur Urol Focus. 2024 Sep;10(5):805-811. doi: 10.1016/j.euf.2024.03.003. Epub 2024 Mar 19. Eur Urol Focus. 2024. PMID: 38508895

18

Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?

Baboudjian M, Diamand R, Uleri A, Beauval JB, Touzani A, Roche JB, Lacetera V, Roumeguère T, Simone G, Benamran D, Fourcade A, Gondran-Tellier B, Fiard G, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: peltier a. Eur Urol. 2024 Sep;86(3):232-237. doi: 10.1016/j.eururo.2024.02.003. Epub 2024 Mar 16. Eur Urol. 2024. PMID: 38494379

19

The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.

Bourgeno HA, Jabbour T, Baudewyns A, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Abou Zahr R, Ploussard G, Fiard G, Halinski A, Rysankova K, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Bui AP, Taha F, Windisch O, Benamran D, Assenmacher G, Vlahopoulos L, Guenzel K, Roumeguère T, Peltier A, Diamand R. Bourgeno HA, et al. Among authors: peltier a. Eur Urol Oncol. 2024 Dec;7(6):1320-1326. doi: 10.1016/j.euo.2024.01.007. Epub 2024 Jan 24. Eur Urol Oncol. 2024. PMID: 38272745

20

Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue.

Jabbour T, Peltier A, Rocq L, Sirtaine N, Lefebvre Y, Bourgeno H, Baudewyns A, Roumeguère T, Diamand R. Jabbour T, et al. Among authors: peltier a. BJU Int. 2024 Apr;133(4):432-441. doi: 10.1111/bju.16221. Epub 2023 Nov 20. BJU Int. 2024. PMID: 37943114

21

Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair Analysis.

Courboin E, Mathieu R, Panetta V, Mjaess G, Diamand R, Verhoest G, Roumiguié M, Bajeot AS, Soria F, Lonati C, Simeone C, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Mertens LS, Sanchez-Salas R, Colomer A, Cerruto MA, Antonelli A, Krajewski W, Quackels T, Peltier A, Montorsi F, Briganti A, Teoh JYC, Pradere B, Moschini M, Roumeguère T, Albisinni S; European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group. Courboin E, et al. Among authors: peltier a. Cancers (Basel). 2023 Sep 26;15(19):4732. doi: 10.3390/cancers15194732. Cancers (Basel). 2023. PMID: 37835425 Free PMC article.

22

PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors.

Shagera QA, Karfis I, Kristanto P, Spyridon S, Diamand R, Santapau A, Peltier A, Roumeguère T, Flamen P, Artigas C. Shagera QA, et al. Among authors: peltier a. J Nucl Med. 2023 Dec 1;64(12):1869-1875. doi: 10.2967/jnumed.123.265874. J Nucl Med. 2023. PMID: 37770114 Free article.

23

External validation of biochemical recurrence definition to predict oncologic outcomes following focal therapy for localized prostate cancer using high intensity focused ultrasound.

Mattlet A, Limani K, Alexandre P, Hawaux E, Abou Zahr R, Aoun F, Diamand R. Mattlet A, et al. Among authors: alexandre p. Prostate. 2023 Dec;83(16):1564-1571. doi: 10.1002/pros.24614. Epub 2023 Aug 13. Prostate. 2023. PMID: 37574824

24

MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients.

Baboudjian M, Uleri A, Beauval JB, Touzani A, Diamand R, Roche JB, Lacetera V, Lechevallier E, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: peltier a. Prostate Cancer Prostatic Dis. 2024 Jun;27(2):318-322. doi: 10.1038/s41391-023-00693-z. Epub 2023 Jul 14. Prostate Cancer Prostatic Dis. 2024. PMID: 37452146

25

Peering through the PSMA PET Lens: The Role of the European Association of Urology Biochemical Recurrence Risk Groups after Radical Prostatectomy.

Leplat C, Jabbour T, Diamand R, Baudewyns A, Bourgeno HA, Shagera QA, Flamen P, Roumeguere T, Peltier A, Artigas C. Leplat C, et al. Among authors: peltier a. Cancers (Basel). 2023 May 26;15(11):2926. doi: 10.3390/cancers15112926. Cancers (Basel). 2023. PMID: 37296888 Free PMC article.

26

Late-onset enteric fistula following radical cystectomy for bladder cancer: A case report.

Baudewyns A, Jabbour T, Bourgeno HA, Peltier A, Diamand R. Baudewyns A, et al. Among authors: peltier a. Urol Case Rep. 2023 May 14;49:102431. doi: 10.1016/j.eucr.2023.102431. eCollection 2023 Jul. Urol Case Rep. 2023. PMID: 37228259 Free PMC article.

27

Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study.

Kwong JCC, Khondker A, Meng E, Taylor N, Kuk C, Perlis N, Kulkarni GS, Hamilton RJ, Fleshner NE, Finelli A, van der Kwast TH, Ali A, Jamal M, Papanikolaou F, Short T, Srigley JR, Colinet V, Peltier A, Diamand R, Lefebvre Y, Mandoorah Q, Sanchez-Salas R, Macek P, Cathelineau X, Eklund M, Johnson AEW, Feifer A, Zlotta AR. Kwong JCC, et al. Among authors: peltier a. Lancet Digit Health. 2023 Jul;5(7):e435-e445. doi: 10.1016/S2589-7500(23)00067-5. Epub 2023 May 19. Lancet Digit Health. 2023. PMID: 37211455 Free article.

28

A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study.

Mjaess G, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S, Diamand R. Mjaess G, et al. Among authors: peltier a. Eur Urol Focus. 2023 Nov;9(6):992-999. doi: 10.1016/j.euf.2023.04.008. Epub 2023 May 3. Eur Urol Focus. 2023. PMID: 37147167

29

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of core number and location.

Martin R, Belahsen Y, Noujeim JP, Lefebvre Y, Lemort M, Deforche M, Sirtaine N, Roumeguere T, Albisinni S, Peltier A, Diamand R. Martin R, et al. Among authors: peltier a. World J Urol. 2023 Jun;41(6):1519-1525. doi: 10.1007/s00345-023-04386-z. Epub 2023 Apr 3. World J Urol. 2023. PMID: 37010577

30

Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.

Baboudjian M, Breda A, Roumeguère T, Uleri A, Roche JB, Touzani A, Lacetera V, Beauval JB, Diamand R, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, Durand-Labrunie C, Roumiguié M, Sanguedolce F, Oderda M, Barret E, Fromont G, Dariane C, Charvet AL, Gondran-Tellier B, Bastide C, Lechevallier E, Palou J, Ruffion A, Van Der Bergh RCN, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: peltier a. World J Urol. 2023 May;41(5):1301-1308. doi: 10.1007/s00345-023-04353-8. Epub 2023 Mar 15. World J Urol. 2023. PMID: 36920491

31

Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculum.

Diamand R, D'Hondt F, Mjaess G, Jabbour T, Dell'Oglio P, Larcher A, Moschini M, Quackels T, Peltier A, Assenmacher G, Wiklund P, Breda A, Turri F, De Groote R, Mottrie A, Roumeguere T, Albisinni S; ERUS Educational Working Group, the Junior ERUS/EAU-YAU Robotic Surgery Working Group and the EAU-YAU Urothelial Carcinoma Working Group. Diamand R, et al. Among authors: peltier a. BJU Int. 2023 Jul;132(1):84-91. doi: 10.1111/bju.15993. Epub 2023 Mar 26. BJU Int. 2023. PMID: 36815233

32

Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry.

Sarkis J, Diamand R, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Minervini A, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Mertens LS, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Pradere B, Moschini M, Roumeguère T, Albisinni S; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. Sarkis J, et al. Among authors: peltier a. Minerva Urol Nephrol. 2023 Feb;75(1):50-58. doi: 10.23736/S2724-6051.22.05109-6. Minerva Urol Nephrol. 2023. PMID: 36800680 Free article.

33

Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.

Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: peltier a. Prostate. 2023 May;83(6):572-579. doi: 10.1002/pros.24490. Epub 2023 Jan 27. Prostate. 2023. PMID: 36705314

34

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.

Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: peltier a. World J Urol. 2023 Jan;41(1):77-84. doi: 10.1007/s00345-022-04244-4. Epub 2022 Dec 12. World J Urol. 2023. PMID: 36509932

35

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.

Noujeim JP, Belahsen Y, Lefebvre Y, Lemort M, Deforche M, Sirtaine N, Martin R, Roumeguère T, Peltier A, Diamand R. Noujeim JP, et al. Among authors: peltier a. Prostate Cancer Prostatic Dis. 2023 Sep;26(3):575-580. doi: 10.1038/s41391-022-00620-8. Epub 2022 Dec 12. Prostate Cancer Prostatic Dis. 2023. PMID: 36509930

36

Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?

Baboudjian M, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Gondran-Tellier B, Roumeguère T, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, VAN DEN Bergh RC, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: peltier a. Minerva Urol Nephrol. 2023 Feb;75(1):124-126. doi: 10.23736/S2724-6051.22.05121-7. Epub 2022 Oct 25. Minerva Urol Nephrol. 2023. PMID: 36282548 Free article. No abstract available.

37

Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.

Baboudjian M, Gondran-Tellier B, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, van den Bergh RCN, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: peltier a. Eur Urol Oncol. 2023 Aug;6(4):406-413. doi: 10.1016/j.euo.2022.09.005. Epub 2022 Oct 21. Eur Urol Oncol. 2023. PMID: 36280445

38

Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.

Oderda M, Albisinni S, Benamran D, Calleris G, Ciccariello M, Dematteis A, Diamand R, Descotes JL, Fiard G, Forte V, Giacobbe A, Marquis A, Marra G, Messas A, Muto G, Peltier A, Rius L, Simone G, Roumeguere T, Faletti R, Gontero P. Oderda M, et al. Among authors: peltier a. Prostate. 2023 Feb;83(2):162-168. doi: 10.1002/pros.24449. Epub 2022 Oct 19. Prostate. 2023. PMID: 36259316

39

Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?

Diamand R, Albisinni S, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, An Nguyen T, Fournier G, Fiard G, Ploussard G, Peltier A, Roumeguère T. Diamand R, et al. Among authors: peltier a. Eur Urol Focus. 2023 Mar;9(2):298-302. doi: 10.1016/j.euf.2022.09.011. Epub 2022 Oct 6. Eur Urol Focus. 2023. PMID: 36210296

40

External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.

Diamand R, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Favre MM, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Peltier A, Albisinni S. Diamand R, et al. Among authors: peltier a. Eur Urol Focus. 2023 Mar;9(2):309-316. doi: 10.1016/j.euf.2022.09.006. Epub 2022 Sep 21. Eur Urol Focus. 2023. PMID: 36153227

41

Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?

Baboudjian M, Roumiguié M, Peltier A, Oderda M, Barret E, Fromont G, Dariane C, Fiard G, Charvet AL, Gondran-Tellier B, Durand-Labrunie C, Campello PV, Roumeguère T, Diamand R, Diana P, Touzani A, Beauval JB, Daniel L, Rouprêt M, Ruffion A, Ploussard G; French Prostate Cancer Committee of the Association Française d’Urologie (CC-AFU). Baboudjian M, et al. Among authors: peltier a. World J Urol. 2022 Oct;40(10):2423-2429. doi: 10.1007/s00345-022-04130-z. Epub 2022 Aug 18. World J Urol. 2022. PMID: 35980449

42

Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison.

Mjaess G, Diamand R, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Tay A, Issa R, Roumiguié M, Bajeot AS, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Mertens LS, Sanchez-Salas R, Gallardo AC, Quackels T, Peltier A, Pradere B, Moschini M, Roumeguère T, Albisinni S; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. Mjaess G, et al. Among authors: peltier a. Eur J Surg Oncol. 2023 Aug;49(8):1511-1518. doi: 10.1016/j.ejso.2022.07.023. Epub 2022 Aug 11. Eur J Surg Oncol. 2023. PMID: 35970622

43

The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric study.

Diamand R, Hollans M, Lefebvre Y, Sirtaine N, Limani K, Hawaux E, Abou Zahr R, Mattlet A, Albisinni S, Roumeguère T, Peltier A. Diamand R, et al. Among authors: peltier a. Urol Oncol. 2022 May;40(5):192.e11-192.e17. doi: 10.1016/j.urolonc.2022.01.011. Epub 2022 Feb 27. Urol Oncol. 2022. PMID: 35236622

44

Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index.

Albisinni S, Diamand R, Mjaess G, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Minervini A, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Sandel N, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Teoh JYC, Pradere B, Moschini M, Roumeguère T. Albisinni S, et al. Among authors: peltier a. J Endourol. 2022 Jun;36(6):785-792. doi: 10.1089/end.2021.0843. Epub 2022 May 17. J Endourol. 2022. PMID: 35109696

45

Modeling present and future climate risk of dengue outbreak, a case study in New Caledonia.

Ochida N, Mangeas M, Dupont-Rouzeyrol M, Dutheil C, Forfait C, Peltier A, Descloux E, Menkes C. Ochida N, et al. Among authors: peltier a. Environ Health. 2022 Jan 20;21(1):20. doi: 10.1186/s12940-022-00829-z. Environ Health. 2022. PMID: 35057822 Free PMC article.

46

⁶⁸Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy.

Shagera QA, Artigas C, Karfis I, Critchi G, Chanza NM, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P. Shagera QA, et al. Among authors: peltier a. J Nucl Med. 2022 Aug;63(8):1191-1198. doi: 10.2967/jnumed.121.263006. Epub 2021 Nov 12. J Nucl Med. 2022. PMID: 34772793 Free article.

47

Oligometastatic Disease Detection with ⁶⁸Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.

Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P. Artigas C, et al. Among authors: peltier a. Cancers (Basel). 2021 Oct 4;13(19):4982. doi: 10.3390/cancers13194982. Cancers (Basel). 2021. PMID: 34638466 Free PMC article.

48

Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.

Albisinni S, Diamand R, Mjaess G, Assenmacher G, Assenmacher C, Loos S, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Di Maida F, Minervini A, Aoun F, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Pradere B, Moschini M, Roumeguère T. Albisinni S, et al. Among authors: peltier a. Urol Oncol. 2022 Apr;40(4):163.e11-163.e17. doi: 10.1016/j.urolonc.2021.08.023. Epub 2021 Sep 25. Urol Oncol. 2022. PMID: 34580028

49

Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens.

Rahota RG, Diamand R, Malavaud B, Fiard G, Descotes JL, Peltier A, Beauval JB, Roumeguère T, Roumiguié M, Albisinni S, Ploussard G. Rahota RG, et al. Among authors: peltier a. BJU Int. 2022 May;129(5):621-626. doi: 10.1111/bju.15563. Epub 2021 Aug 22. BJU Int. 2022. PMID: 34358405

50

Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses.

Mjaess G, Chebel R, Karam A, Moussa I, Pretot D, Abi Tayeh G, Sarkis J, Semaan A, Peltier A, Aoun F, Albisinni S, Roumeguère T. Mjaess G, et al. Among authors: peltier a. Acta Oncol. 2021 Jun;60(6):704-713. doi: 10.1080/0284186X.2021.1886323. Epub 2021 Feb 15. Acta Oncol. 2021. PMID: 33586577

51

Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications.

Diamand R, Ploussard G, Roumiguié M, Malavaud B, Oderda M, Gontero P, Fourcade A, Fournier G, Benamran D, Iselin C, Fiard G, Descotes JL, Peltier A, Simone G, Roche JB, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: peltier a. Urol Oncol. 2021 May;39(5):296.e1-296.e9. doi: 10.1016/j.urolonc.2020.08.030. Epub 2020 Oct 9. Urol Oncol. 2021. PMID: 33041188

52

External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.

Diamand R, Ploussard G, Roumiguié M, Oderda M, Benamran D, Fiard G, Quackels T, Assenmacher G, Simone G, Van Damme J, Malavaud B, Iselin C, Descotes JL, Roche JB, Peltier A, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: peltier a. Eur Urol. 2021 Feb;79(2):180-185. doi: 10.1016/j.eururo.2020.09.037. Epub 2020 Oct 3. Eur Urol. 2021. PMID: 33023770

53

Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.

Oderda M, Diamand R, Albisinni S, Calleris G, Carbone A, Falcone M, Fiard G, Gandaglia G, Marquis A, Marra G, Parola C, Pastore A, Peltier A, Ploussard G, Roumeguère T, Sanchez-Salas R, Simone G, Smelzo S, Witt JH, Gontero P. Oderda M, et al. Among authors: peltier a. BJU Int. 2021 Mar;127(3):318-325. doi: 10.1111/bju.15220. Epub 2020 Sep 19. BJU Int. 2021. PMID: 32869940 Free article.

54

Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.

Diamand R, Ploussard G, Roumiguié M, Oderda M, Benamran D, Fiard G, Peltier A, Simone G, Van Damme J, Malavaud B, Iselin C, Descotes JL, Roche JB, Quackels T, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: peltier a. World J Urol. 2021 Jun;39(6):1789-1796. doi: 10.1007/s00345-020-03402-w. Epub 2020 Aug 10. World J Urol. 2021. PMID: 32776243 Free PMC article.

55

External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study.

Diamand R, Oderda M, Albisinni S, Fourcade A, Fournier G, Benamran D, Iselin C, Fiard G, Descotes JL, Assenmacher G, Svistakov I, Peltier A, Simone G, Di Cosmo G, Roche JB, Bonnal JL, Van Damme J, Rossi M, Mandron E, Gontero P, Roumeguère T. Diamand R, et al. Among authors: peltier a. Urol Oncol. 2020 Nov;38(11):847.e9-847.e16. doi: 10.1016/j.urolonc.2020.04.011. Epub 2020 May 26. Urol Oncol. 2020. PMID: 32466877

56

Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients.

Plouznikoff N, Artigas C, Sideris S, Martinez Chanza N, Gil T, Peltier A, Flamen P. Plouznikoff N, et al. Among authors: peltier a. Ann Nucl Med. 2019 Dec;33(12):945-954. doi: 10.1007/s12149-019-01404-2. Epub 2019 Oct 5. Ann Nucl Med. 2019. PMID: 31587172

57

Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer.

Aoun F, Albisinni S, Biaou I, Peltier A, Limani K, Roumeguère T, van Velthoven R. Aoun F, et al. Among authors: peltier a. Prog Urol. 2019 Oct;29(12):627-633. doi: 10.1016/j.purol.2019.06.004. Epub 2019 Aug 7. Prog Urol. 2019. PMID: 31400963

58

Testicular microlithiasis: Systematic review and Clinical guidelines.

Aoun F, Slaoui A, Naoum E, Hassan T, Albisinni S, Azzo JM, Kallas-Chemaly A, Assenmacher G, Peltier A, Roumeguère T. Aoun F, et al. Among authors: peltier a. Prog Urol. 2019 Sep;29(10):465-473. doi: 10.1016/j.purol.2019.07.001. Epub 2019 Aug 2. Prog Urol. 2019. PMID: 31383508

59

Validated Prospective Assessment of Quality of Life After Robot-Assisted Laparoscopic Prostatectomy: Beyond Continence and Erections.

Albisinni S, Aoun F, Quackels T, Assenmacher G, Peltier A, van Velthoven R, Roumeguère T. Albisinni S, et al. Among authors: peltier a. Am J Mens Health. 2019 May-Jun;13(3):1557988319854555. doi: 10.1177/1557988319854555. Am J Mens Health. 2019. PMID: 31148505 Free PMC article.

60

Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.

Devos B, Al Hajj Obeid W, Andrianne C, Diamand R, Peltier A, Everaerts W, Van Poppel H, Van Velthoven R, Joniau S. Devos B, et al. Among authors: peltier a. World J Urol. 2019 Aug;37(8):1507-1515. doi: 10.1007/s00345-019-02640-x. Epub 2019 Jan 21. World J Urol. 2019. PMID: 30666400

61

Association between phosphodiesterase type 5 inhibitors and prostate cancer: A systematic review.

Aoun F, Slaoui A, Walid AHO, Albisinni S, Assenmacher G, de Plaen E, Azzo JM, Peltier A, Roumeguère T. Aoun F, et al. Among authors: peltier a. Prog Urol. 2018 Oct;28(12):560-566. doi: 10.1016/j.purol.2018.07.004. Epub 2018 Sep 7. Prog Urol. 2018. PMID: 30201551

62

Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients.

Oderda M, Marra G, Albisinni S, Altobelli E, Baco E, Beatrici V, Cantiani A, Carbone A, Ciccariello M, Descotes JL, Dubreuil-Chambardel M, Eldred-Evans D, Fasolis G, Ferriero M, Fiard G, Forte V, Giacobbe A, Kumar P, Lacetera V, Mozer P, Muto G, Papalia R, Pastore A, Peltier A, Piechaud T, Simone G, Roche JB, Roupret M, Rouviere O, Van Velthoven R, Gontero P. Oderda M, et al. Among authors: peltier a. Int J Urol. 2018 Dec;25(12):990-997. doi: 10.1111/iju.13796. Epub 2018 Sep 5. Int J Urol. 2018. PMID: 30187529

63

Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data.

Albisinni S, Mélot C, Aoun F, Limani K, Peltier A, Rischmann P, van Velthoven R. Albisinni S, et al. Among authors: peltier a. J Endourol. 2018 Sep 12;32(9):797-804. doi: 10.1089/end.2018.0130. Epub 2018 Jun 27. J Endourol. 2018. PMID: 29790383 Review.

64

Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.

El Rassy E, Aoun F, Sleilaty G, Kattan J, Banyurwabuke B, Zanaty M, Bakouny Z, Albisinni S, Peltier A, Roumeguere T. El Rassy E, et al. Among authors: peltier a. Future Oncol. 2017 Dec;13(29):2709-2717. doi: 10.2217/fon-2017-0268. Epub 2017 Nov 29. Future Oncol. 2017. PMID: 29183164

65

A Hard Ball for a Tennis Player: A Rare Case of Large Calcifying Sertoli Cell Testicular Tumor.

Albisinni S, Biaou I, Aoun F, Diamand R, Limani K, Peltier A, van Velthoven R, Hawaux E. Albisinni S, et al. Among authors: peltier a. Urol Case Rep. 2017 Apr 27;13:55-57. doi: 10.1016/j.eucr.2017.01.007. eCollection 2017 Jul. Urol Case Rep. 2017. PMID: 28480167 Free PMC article.

66

Androgen deprivation therapy in the treatment of locally advanced, nonmetastatic prostate cancer: practical experience and a review of the clinical trial evidence.

Aoun F, Bourgi A, Ayoub E, El Rassy E, van Velthoven R, Peltier A. Aoun F, et al. Among authors: peltier a. Ther Adv Urol. 2017 Mar 1;9(3-4):73-80. doi: 10.1177/1756287217697661. eCollection 2017 Mar-Apr. Ther Adv Urol. 2017. PMID: 28392836 Free PMC article. Review.

67

Management of Anastomosis Leakage Post-RALP: A Simple Trick for a Complex Situation.

Diamand R, Al Hajj Obeid W, Accarain A, Limani K, Hawaux E, van Velthoven R, Peltier A. Diamand R, et al. Among authors: peltier a. Urol Case Rep. 2017 Mar 6;12:28-30. doi: 10.1016/j.eucr.2017.02.003. eCollection 2017 May. Urol Case Rep. 2017. PMID: 28280688 Free PMC article.

68

Bladder cancer immunotherapy: swinging for the fences.

Aoun F, El Rassy E, Peltier A. Aoun F, et al. Among authors: peltier a. Future Oncol. 2017 Apr;13(9):773-775. doi: 10.2217/fon-2017-0013. Epub 2017 Feb 10. Future Oncol. 2017. PMID: 28183191 No abstract available.

69

Comparing conventional laparoscopic to robotic-assisted extended pelvic lymph node dissection in men with intermediate and high-risk prostate cancer: a matched-pair analysis.

Albisinni S, Aoun F, LE Dinh D, Zanaty M, Hawaux E, Peltier A, VAN Velthoven R. Albisinni S, et al. Among authors: peltier a. Minerva Urol Nefrol. 2017 Feb;69(1):101-107. doi: 10.23736/S0393-2249.16.02799-5. Epub 2016 Nov 10. Minerva Urol Nefrol. 2017. PMID: 28009151

70

Clinical impact of ⁶⁸ Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach.

Albisinni S, Artigas C, Aoun F, Biaou I, Grosman J, Gil T, Hawaux E, Limani K, Otte FX, Peltier A, Sideris S, Sirtaine N, Flamen P, van Velthoven R. Albisinni S, et al. Among authors: peltier a. BJU Int. 2017 Aug;120(2):197-203. doi: 10.1111/bju.13739. Epub 2017 Jan 4. BJU Int. 2017. PMID: 27981732

71

Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.

Albisinni S, Aoun F, Bellucci S, Biaou I, Limani K, Hawaux E, Peltier A, van Velthoven R. Albisinni S, et al. Among authors: peltier a. J Endourol. 2017 Jan;31(1):14-19. doi: 10.1089/end.2016.0702. Epub 2016 Nov 30. J Endourol. 2017. PMID: 27799004

72

Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.

Gil T, Sideris S, Aoun F, van Velthoven R, Sirtaine N, Paesmans M, Ameye L, Awada A, Devriendt D, Peltier A. Gil T, et al. Among authors: peltier a. Mol Clin Oncol. 2016 Sep;5(3):258-264. doi: 10.3892/mco.2016.960. Epub 2016 Jul 14. Mol Clin Oncol. 2016. PMID: 27588190 Free PMC article.

73

The Single-Knot Running Vesicourethral Anastomosis after Minimally Invasive Prostatectomy: Review of the Technique and Its Modifications, Tips, and Pitfalls.

Albisinni S, Aoun F, Peltier A, van Velthoven R. Albisinni S, et al. Among authors: peltier a. Prostate Cancer. 2016;2016:1481727. doi: 10.1155/2016/1481727. Epub 2016 May 31. Prostate Cancer. 2016. PMID: 27340567 Free PMC article. Review.

74

Adapting the robotic platform to small operating theaters: our experience with the side-docking technique for robotic-assisted laparoscopic prostatectomy.

Albisinni S, Aoun F, Le Dinh D, Limani K, Hawaux E, Peltier A, van Velthoven R. Albisinni S, et al. Among authors: peltier a. Surg Endosc. 2016 Oct;30(10):4464-8. doi: 10.1007/s00464-016-4777-1. Epub 2016 Feb 5. Surg Endosc. 2016. PMID: 26850025

75

Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy.

Goris Gbenou MC, Peltier A, Schulman CC, Velthoven Rv. Goris Gbenou MC, et al. Among authors: peltier a. Urol Oncol. 2016 Jun;34(6):254.e1-6. doi: 10.1016/j.urolonc.2015.12.009. Epub 2016 Jan 25. Urol Oncol. 2016. PMID: 26822075

76

Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.

Peltier A, Aoun F, Albisinni S, Marcelis Q, Ledinh D, Paesmans M, Lemort M, van Velthoven R. Peltier A, et al. Scand J Urol. 2016 Jun;50(3):144-8. doi: 10.3109/21681805.2015.1118408. Epub 2016 Jan 12. Scand J Urol. 2016. PMID: 26754860

77

Bladder sparing robot-assisted laparoscopic en bloc resection of urachus and umbilicus for urachal adenocarcinoma.

Aoun F, Peltier A, van Velthoven R. Aoun F, et al. Among authors: peltier a. J Robot Surg. 2015 Jun;9(2):167-70. doi: 10.1007/s11701-015-0507-2. Epub 2015 Mar 21. J Robot Surg. 2015. PMID: 26531120

78

Head docking for single stage robotic cortical sparing adrenalectomy for bilateral pheochromocytoma.

Aoun F, Peltier A, van Velthoven R. Aoun F, et al. Among authors: peltier a. J Robot Surg. 2015 Mar;9(1):79-83. doi: 10.1007/s11701-014-0487-7. Epub 2014 Sep 4. J Robot Surg. 2015. PMID: 26530976

79

Does Multimedia Education with 3D Animation Impact Quality and Duration of Urologists' Interactions with their Prostate Cancer Patients?

Peltier A, Aoun F, Ameye F, Andrianne R, De Meerleer G, Denis L, Joniau S, Lambrecht A, Billiet I, Vanderdonck F, Roumeguère T, Van Velthoven R. Peltier A, et al. Adv Ther. 2015 Sep;32(9):863-73. doi: 10.1007/s12325-015-0248-7. Epub 2015 Sep 25. Adv Ther. 2015. PMID: 26407808

80

High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis.

Aoun F, Limani K, Peltier A, Marcelis Q, Zanaty M, Chamoun A, Vanden Bossche M, Roumeguère T, van Velthoven R. Aoun F, et al. Among authors: peltier a. Adv Urol. 2015;2015:350324. doi: 10.1155/2015/350324. Epub 2015 Aug 19. Adv Urol. 2015. PMID: 26357511 Free PMC article.

81

Penile rehabilitation after pelvic cancer surgery.

Aoun F, Peltier A, van Velthoven R. Aoun F, et al. Among authors: peltier a. ScientificWorldJournal. 2015;2015:876046. doi: 10.1155/2015/876046. Epub 2015 Feb 15. ScientificWorldJournal. 2015. PMID: 25785286 Free PMC article. Review.

82

Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study.

Peltier A, Aoun F, De Ruyter V, Cabri P, Van Velthoven R. Peltier A, et al. Prostate Cancer. 2015;2015:978194. doi: 10.1155/2015/978194. Epub 2015 Jan 28. Prostate Cancer. 2015. PMID: 25694830 Free PMC article.

83

MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men.

Peltier A, Aoun F, Lemort M, Kwizera F, Paesmans M, Van Velthoven R. Peltier A, et al. Biomed Res Int. 2015;2015:571708. doi: 10.1155/2015/571708. Epub 2015 Jan 27. Biomed Res Int. 2015. PMID: 25692142 Free PMC article. Clinical Trial.

84

Penile Rehabilitation Strategies Among Prostate Cancer Survivors.

Aoun F, Peltier A, van Velthoven R. Aoun F, et al. Among authors: peltier a. Rev Urol. 2015;17(2):58-68. doi: 10.3909/riu0652. Rev Urol. 2015. PMID: 27222641 Free PMC article.

85

Lower urinary tract dysfunction in pelvic gynecologic cancer: the role of urodynamics.

Aoun F, Peltier A, van Velthoven R. Aoun F, et al. Among authors: peltier a. Adv Urol. 2014;2014:303958. doi: 10.1155/2014/303958. Epub 2014 Nov 23. Adv Urol. 2014. PMID: 25506360 Free PMC article. Review.

86

A comprehensive review of contemporary role of local treatment of the primary tumor and/or the metastases in metastatic prostate cancer.

Aoun F, Peltier A, van Velthoven R. Aoun F, et al. Among authors: peltier a. Biomed Res Int. 2014;2014:501213. doi: 10.1155/2014/501213. Epub 2014 Nov 17. Biomed Res Int. 2014. PMID: 25485280 Free PMC article. Review.

87

Evaluation of the single-knot running vesicourethral anastomosis 10 years after its introduction: results from an international survey.

Albisinni S, Limani K, Hawaux E, Peltier A, Van Velthoven R. Albisinni S, et al. Among authors: peltier a. J Laparoendosc Adv Surg Tech A. 2014 Sep;24(9):640-6. doi: 10.1089/lap.2014.0129. J Laparoendosc Adv Surg Tech A. 2014. PMID: 25192249

88

Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes.

Limani K, Aoun F, Holz S, Paesmans M, Peltier A, van Velthoven R. Limani K, et al. Among authors: peltier a. Prostate Cancer. 2014;2014:186782. doi: 10.1155/2014/186782. Epub 2014 Jun 19. Prostate Cancer. 2014. PMID: 25045541 Free PMC article.

89

Primary Zonal High Intensity Focused Ultrasound for Prostate Cancer: Results of a Prospective Phase IIa Feasibility Study.

Van Velthoven R, Aoun F, Limani K, Narahari K, Lemort M, Peltier A. Van Velthoven R, et al. Among authors: peltier a. Prostate Cancer. 2014;2014:756189. doi: 10.1155/2014/756189. Epub 2014 Jan 23. Prostate Cancer. 2014. PMID: 24587908 Free PMC article.

90

Long-term evaluation of oncologic and functional outcomes after laparoscopic open-assisted radical cystectomy: a matched-pair analysis.

Albisinni S, Limani K, Ingels L, Kwizera F, Bollens R, Hawaux E, Quackels T, Vanden Bossche M, Peltier A, Roumeguère T, van Velthoven R. Albisinni S, et al. Among authors: peltier a. World J Urol. 2014 Dec;32(6):1455-61. doi: 10.1007/s00345-014-1245-1. Epub 2014 Jan 28. World J Urol. 2014. PMID: 24469859

91

3D versus 2D Systematic Transrectal Ultrasound-Guided Prostate Biopsy: Higher Cancer Detection Rate in Clinical Practice.

Peltier A, Aoun F, El-Khoury F, Hawaux E, Limani K, Narahari K, Sirtaine N, van Velthoven R. Peltier A, et al. Prostate Cancer. 2013;2013:783243. doi: 10.1155/2013/783243. Epub 2013 Nov 17. Prostate Cancer. 2013. PMID: 24349788 Free PMC article.

92

Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).

Simmons LA, Autier P, Zát'ura F, Braeckman J, Peltier A, Romic I, Stenzl A, Treurnicht K, Walker T, Nir D, Moore CM, Emberton M. Simmons LA, et al. Among authors: peltier a. BJU Int. 2012 Jul;110(1):28-35. doi: 10.1111/j.1464-410X.2011.10734.x. Epub 2011 Nov 17. BJU Int. 2012. PMID: 22093966

93

Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.

Goris Gbenou MC, Peltier A, Addla SK, Lemort M, Bollens R, Larsimont D, Roumeguère T, Schulman CC, van Velthoven R. Goris Gbenou MC, et al. Among authors: peltier a. Urol Int. 2012;88(1):12-7. doi: 10.1159/000331909. Epub 2011 Oct 15. Urol Int. 2012. PMID: 22004874

94

Current management of erectile dysfunction after cancer treatment.

Peltier A, van Velthoven R, Roumeguère T. Peltier A, et al. Curr Opin Oncol. 2009 Jul;21(4):303-9. doi: 10.1097/CCO.0b013e32832b9d76. Curr Opin Oncol. 2009. PMID: 19509501 Review.

95

Mentor-initiated approach in laparoscopic radical prostatectomy.

Skrekas T, Mochtar CA, Lagerveld BW, de Reijke TM, van Velthoven RF, Peltier A, de la Rosette JJ, Laguna MP. Skrekas T, et al. Among authors: peltier a. J Endourol. 2006 Oct;20(10):831-5. doi: 10.1089/end.2006.20.831. J Endourol. 2006. PMID: 17094764

96

Technique for laparoscopic running urethrovesical anastomosis:the single knot method.

Van Velthoven RF, Ahlering TE, Peltier A, Skarecky DW, Clayman RV. Van Velthoven RF, et al. Among authors: peltier a. Urology. 2003 Apr;61(4):699-702. doi: 10.1016/s0090-4295(02)02543-8. Urology. 2003. PMID: 12670546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year